Clinical Trial Update: A Study of ALN-PCSSC in Participants With Homozygous Familial Hypercholesterolemia (HoFH) [Phase 2]

View source ↗

Summary

Phase 2 trial update for ALN-PCSSC in participants with homozygous familial hypercholesterolemia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Homozygous Familial Hypercholesterolemia

Drugs mentioned

• ALN-PCSSC

Snippet

Sponsor: The Medicines Company | Conditions: Homozygous Familial Hypercholesterolemia | Phase 2 | Status: COMPLETED | Results posted: 2020-05-18